Vanderbilt University

Young Scientist Journal

Current Volume
Editorial Letter
- May 2025
- May 2024
- May 2023
- May 2022
- May 2021
- May 2020
- May 2019
- May 2018
- May 2017
- May 2016
- May 2015
- May 2014
- May 2013
- May 2012
- May 2011
Contact Us
Article Submission
Home

Vanderbilt University

Current Volume
Editorial Letter
Archives
- May 2025
- May 2024
- May 2023
- May 2022
- May 2021
- May 2020
- May 2019
- May 2018
- May 2017
- May 2016
- May 2015
- May 2014
- May 2013
- May 2012
- May 2011
Contact Us
Article Submission
Home

About
Academics
- Academics Overview
- Program Finder
Admissions
Athletics
Campus Life
Research
News

Adverse Drug Reaction (ADR)

Defining the Immunogenomics of Allopurinol-Induced SJS/TEN

May 30, 2023

Vanderbilt University

University Leadership
Residential Colleges
This Is Vanderbilt
Research@Vanderbilt

Working at Vanderbilt
Events
Logins
Campus Map
Media Resources

Nashville, Tennessee 37240

615-322-7311 • Contact Us

Vanderbilt University’s Online Privacy Notice

Twitter
Threads
Facebook
Instagram
YouTube
TikTok
LinkedIn

Vanderbilt University is committed to the principle of equal opportunity. Vanderbilt University does not discriminate against individuals on the basis of their race, sex, sexual orientation, gender identity, religion, color, national or ethnic origin, age, disability, military service, or genetic information in its administration of educational policies, programs, or activities; admissions policies; scholarship and loan programs; athletic or other University-administered programs; or employment. Accessibility information. Vanderbilt®, Vanderbilt University® and the Vanderbilt logos are trademarks of The Vanderbilt University. Site Development: Digital Strategies (Communications and Marketing.) © 2026

Adverse Drug Reaction (ADR)

Defining the Immunogenomics of Allopurinol-Induced SJS/TEN